Found: 133
Select item for more details and to access through your institution.
Wege zur Therapie neuromuskulärer Erkrankungen in der Neuropädiatrie und Neurologie.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Immuntherapie und personalisierte Behandlung bei Multipler Sklerose.
- Published in:
- Der Nervenarzt, 2021, v. 92, n. 10, p. 986, doi. 10.1007/s00115-021-01176-z
- By:
- Publication type:
- Article
Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper).
- Published in:
- Der Nervenarzt, 2021, v. 92, n. 8, p. 773, doi. 10.1007/s00115-021-01157-2
- By:
- Publication type:
- Article
Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose: Aktueller Stand und Empfehlungen in Deutschland.
- Published in:
- Der Nervenarzt, 2019, v. 90, n. 12, p. 1245, doi. 10.1007/s00115-019-0760-0
- By:
- Publication type:
- Article
Decline and Recurrence of Stroke Consultations during the COVID-19 Pandemic Lockdown Parallels Population Activity Levels.
- Published in:
- Cerebrovascular Diseases, 2021, v. 50, n. 3, p. 317, doi. 10.1159/000514154
- By:
- Publication type:
- Article
Transcranial Doppler sonography and the effect of haematopoietic stem cell transplantation in sickle cell disease.
- Published in:
- Neurological Research & Practice, 2022, v. 4, n. 1, p. 1, doi. 10.1186/s42466-022-00175-y
- By:
- Publication type:
- Article
Transcranial Doppler sonography and the effect of haematopoietic stem cell transplantation in sickle cell disease.
- Published in:
- Neurological Research & Practice, 2022, v. 4, n. 1, p. 1, doi. 10.1186/s42466-022-00175-y
- By:
- Publication type:
- Article
Index event of cerebral amyloid angiopathy (CAA) determines long-term prognosis and recurrent events (retrospective analysis and clinical follow-up).
- Published in:
- Neurological Research & Practice, 2021, v. 3, n. 1, p. 1, doi. 10.1186/s42466-021-00152-x
- By:
- Publication type:
- Article
Informal Caregiving in Amyotrophic Lateral Sclerosis (ALS): A High Caregiver Burden and Drastic Consequences on Caregivers' Lives.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 6, p. 748, doi. 10.3390/brainsci11060748
- By:
- Publication type:
- Article
Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.991291
- By:
- Publication type:
- Article
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 5, p. 661, doi. 10.1177/1352458518763541
- By:
- Publication type:
- Article
Dietary fatty acids and susceptibility to multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 1, p. 12, doi. 10.1177/1352458517737372
- By:
- Publication type:
- Article
Role of glial 14-3-3 gamma protein in autoimmune demyelination.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Pain in experimental autoimmune encephalitis: a comparative study between different mouse models.
- Published in:
- Journal of Neuroinflammation, 2012, v. 9, n. 1, p. 1, doi. 10.1186/1742-2094-9-233
- By:
- Publication type:
- Article
Pain in experimental autoimmune encephalitis: a comparative study between different mouse models.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Multiple sclerosis in families: risk factors beyond known genetic polymorphisms.
- Published in:
- Neurogenetics, 2016, v. 17, n. 2, p. 131, doi. 10.1007/s10048-016-0474-4
- By:
- Publication type:
- Article
Longitudinal Sodium MRI of Multiple Sclerosis Lesions: Is there Added Value of Sodium Inversion Recovery MRI.
- Published in:
- Journal of Magnetic Resonance Imaging, 2022, v. 55, n. 1, p. 140, doi. 10.1002/jmri.27832
- By:
- Publication type:
- Article
Macrophages in neuroinflammation: role of the renin-angiotensin-system.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2017, v. 469, n. 3/4, p. 431, doi. 10.1007/s00424-017-1942-x
- By:
- Publication type:
- Article
Sodium chloride, SGK1, and Th17 activation.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2015, v. 467, n. 3, p. 543, doi. 10.1007/s00424-014-1659-z
- By:
- Publication type:
- Article
Real-world analysis of brain atrophy in multiple sclerosis patients with an artificial intelligence based software tool.
- Published in:
- Neurological Research & Practice, 2024, v. 6, n. 1, p. 1, doi. 10.1186/s42466-024-00339-y
- By:
- Publication type:
- Article
Neuromonitoring Using Neurosonography and Pupillometry in A Weaning and Early Neurorehabilitation Unit.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Brain MRI Lesions are Related to Bowel Incontinence in Multiple Sclerosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dietary galactose exacerbates autoimmune neuroinflammation via advanced glycation end product-mediated neurodegeneration.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1367819
- By:
- Publication type:
- Article
Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side Effects.
- Published in:
- Current Neurology & Neuroscience Reports, 2013, v. 13, n. 11, p. 1, doi. 10.1007/s11910-013-0394-8
- By:
- Publication type:
- Article
Neuroanatomic Correlates of Female Sexual Dysfunction in Multiple Sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters.
- Published in:
- International Journal of Molecular Sciences, 2012, v. 13, n. 9, p. 11783, doi. 10.3390/ijms130911783
- By:
- Publication type:
- Article
Outcome of glioblastoma patients after intensive care unit admission with invasive mechanical ventilation: a multicenter analysis.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 1, p. 249, doi. 10.1007/s11060-023-04403-6
- By:
- Publication type:
- Article
Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination.
- Published in:
- Acta Neuropathologica, 2012, v. 123, n. 2, p. 247, doi. 10.1007/s00401-011-0890-3
- By:
- Publication type:
- Article
The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 6, p. 668, doi. 10.1002/acn3.553
- By:
- Publication type:
- Article
Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective study.
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 5, p. 446, doi. 10.1093/nop/npad023
- By:
- Publication type:
- Article
Oral Health, Oral Microbiota, and Incidence of Stroke-Associated Pneumonia—A Prospective Observational Study.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.528056
- By:
- Publication type:
- Article
Interdisciplinary Decision Making in Hemorrhagic Stroke Based on CT Imaging—Differences Between Neurologists and Neurosurgeons Regarding Estimation of Patients' Symptoms, Glasgow Coma Scale, and National Institutes of Health Stroke Scale.
- Published in:
- Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.00997
- By:
- Publication type:
- Article
Plasmapheresis for neuroinflammatory disorders.
- Published in:
- Clinical & Experimental Neuroimmunology, 2010, v. 1, n. 3, p. 95, doi. 10.1111/j.1759-1961.2010.00010.x
- By:
- Publication type:
- Article
Brain-Derived Neurotrophic Factor in Neuroimmunology: Lessons Learned from Multiple Sclerosis Patients and Experimental Autoimmune Encephalomyelitis Models.
- Published in:
- Archivum Immunologiae & Therapiae Experimentalis, 2013, v. 61, n. 2, p. 95, doi. 10.1007/s00005-012-0211-0
- By:
- Publication type:
- Article
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.
- Published in:
- Molecular Neurodegeneration, 2014, v. 9, n. 1, p. 108, doi. 10.1186/1750-1326-9-49
- By:
- Publication type:
- Article
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis.
- Published in:
- CNS Neuroscience & Therapeutics, 2016, v. 22, n. 12, p. 1019, doi. 10.1111/cns.12652
- By:
- Publication type:
- Article
POLAR: prediction of prolonged mechanical ventilation in patients with myasthenic crisis.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 5, p. 2875, doi. 10.1007/s00415-024-12208-4
- By:
- Publication type:
- Article
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 4, p. 1515, doi. 10.1007/s00415-023-12007-3
- By:
- Publication type:
- Article
Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 10, p. 4922, doi. 10.1007/s00415-023-11811-1
- By:
- Publication type:
- Article
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 1, p. 165, doi. 10.1007/s00415-018-9117-z
- By:
- Publication type:
- Article
Peripheral CD19<sup>+</sup> B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 1, p. 57, doi. 10.1007/s00415-018-9092-4
- By:
- Publication type:
- Article
Lesion correlates of secondary paroxysmal dyskinesia in multiple sclerosis.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 10, p. 2277, doi. 10.1007/s00415-018-8989-2
- By:
- Publication type:
- Article
Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 7, p. 1521, doi. 10.1007/s00415-018-8871-2
- By:
- Publication type:
- Article
Insular multiple sclerosis lesions are associated with erectile dysfunction.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 4, p. 783, doi. 10.1007/s00415-018-8763-5
- By:
- Publication type:
- Article
Site and size of multiple sclerosis lesions predict enhanced or decreased female orgasmic function.
- Published in:
- Journal of Neurology, 2015, v. 262, n. 12, p. 2731, doi. 10.1007/s00415-015-7907-0
- By:
- Publication type:
- Article
Western lifestyle and immunopathology of multiple sclerosis.
- Published in:
- Annals of the New York Academy of Sciences, 2018, v. 1417, n. 1, p. 71, doi. 10.1111/nyas.13583
- By:
- Publication type:
- Article
Cardiovascular fingolimod effects on rapid baroreceptor unloading are counterbalanced by baroreflex resetting.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 1, p. 111, doi. 10.1007/s10072-020-05004-1
- By:
- Publication type:
- Article
Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 3, p. 1263, doi. 10.1002/cam4.2767
- By:
- Publication type:
- Article